Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,936 | 173 | 97.3% |
| Travel and Lodging | $88.94 | 1 | 2.2% |
| Gift | $19.40 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $799.87 | 40 | $0 (2024) |
| Allergan, Inc. | $612.36 | 29 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $429.86 | 18 | $0 (2024) |
| ABBVIE INC. | $407.48 | 22 | $0 (2024) |
| Shire North American Group Inc | $351.87 | 10 | $0 (2019) |
| Alcon Vision LLC | $187.88 | 8 | $0 (2024) |
| NEW WORLD MEDICAL,INC. | $185.77 | 1 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $169.11 | 9 | $0 (2021) |
| Tarsus Pharmaceuticals, Inc. | $141.94 | 6 | $0 (2024) |
| Amgen Inc. | $103.64 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $771.99 | 33 | Bausch & Lomb Americas Inc. ($208.33) |
| 2023 | $634.14 | 23 | NEW WORLD MEDICAL,INC. ($185.77) |
| 2022 | $545.69 | 28 | ABBVIE INC. ($144.14) |
| 2021 | $296.10 | 17 | Allergan, Inc. ($111.54) |
| 2020 | $170.66 | 9 | Allergan, Inc. ($46.65) |
| 2019 | $424.41 | 26 | Allergan Inc. ($172.15) |
| 2018 | $698.54 | 20 | Allergan Inc. ($282.02) |
| 2017 | $502.83 | 19 | Sun Pharmaceutical Industries Inc. ($146.70) |
All Payment Transactions
175 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: EYE CARE | ||||||
| 11/11/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/18/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: EYE CARE | ||||||
| 10/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Ophthalmology | ||||||
| 10/04/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: SOLUTION/ DROPS | ||||||
| 09/30/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/11/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: EYE CARE | ||||||
| 08/29/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/19/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Ophthalmology | ||||||
| 08/15/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $106.67 | General |
| Category: Ophthalmology | ||||||
| 08/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Ophthalmology | ||||||
| 08/09/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $47.45 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/08/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: EYE CARE | ||||||
| 08/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/31/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Ophthalmology | ||||||
| 07/24/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: EYE CARE | ||||||
| 06/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Ophthalmology | ||||||
| 05/29/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/06/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 884 | 1,026 | $285,470 | $93,789 |
| 2022 | 14 | 878 | 1,005 | $260,470 | $88,385 |
| 2021 | 14 | 737 | 832 | $193,600 | $70,090 |
| 2020 | 12 | 551 | 632 | $130,770 | $45,217 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 49 | 63 | $94,500 | $27,790 | 29.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 145 | 204 | $36,720 | $14,706 | 40.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 137 | 146 | $36,500 | $14,111 | 38.7% |
| 66761 | Creation of eye fluid drainage tracts in iris using a laser, per session | Office | 2023 | 25 | 42 | $25,200 | $10,572 | 42.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 77 | 77 | $23,100 | $8,503 | 36.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 85 | 104 | $15,600 | $5,322 | 34.1% |
| 92134 | Imaging of retina | Office | 2023 | 140 | 142 | $14,200 | $4,667 | 32.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 67 | 88 | $22,000 | $2,980 | 13.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 77 | 78 | $7,800 | $2,259 | 29.0% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 29 | 29 | $5,800 | $1,934 | 33.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 34 | 34 | $2,720 | $767.25 | 28.2% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 19 | 19 | $1,330 | $178.20 | 13.4% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 42 | 54 | $81,000 | $23,665 | 29.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 138 | 147 | $36,750 | $14,166 | 38.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 111 | 173 | $31,140 | $12,346 | 39.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 92 | 92 | $27,600 | $11,381 | 41.2% |
| 66761 | Creation of eye fluid drainage tracts in iris using a laser, per session | Office | 2022 | 21 | 29 | $17,400 | $7,811 | 44.9% |
| 92134 | Imaging of retina | Office | 2022 | 148 | 155 | $15,500 | $5,356 | 34.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 89 | 102 | $15,300 | $5,312 | 34.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 50 | 64 | $16,000 | $2,466 | 15.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 71 | 73 | $7,300 | $2,116 | 29.0% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 24 | 24 | $4,800 | $1,840 | 38.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 51 | 51 | $4,080 | $1,227 | 30.1% |
| 92250 | Photography of the retina | Office | 2022 | 11 | 11 | $1,650 | $351.88 | 21.3% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 15 | 15 | $900.00 | $201.68 | 22.4% |
About Dr. Andrea Jue, M.D
Dr. Andrea Jue, M.D is a Ophthalmology healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1699970129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrea Jue, M.D has received a total of $4,044 in payments from pharmaceutical and medical device companies, with $771.99 received in 2024. These payments were reported across 175 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,936).
As a Medicare-enrolled provider, Jue has provided services to 3,050 Medicare beneficiaries, totaling 3,495 services with total Medicare billing of $297,481. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Daly City, CA
- Active Since 06/15/2007
- Last Updated 12/26/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1699970129
Products in Payments
- LUMIGAN (Drug) $528.70
- XIIDRA (Drug) $463.41
- Cequa (Drug) $332.52
- VYZULTA (Drug) $249.29
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $188.38
- MIEBO (Drug) $167.27
- XEN (Device) $149.99
- Bromsite (Drug) $146.70
- XDEMVY (Drug) $141.94
- COMBIGAN (Drug) $125.92
- HYDRUS Microstent (Device) $110.19
- VUITY (Drug) $106.47
- TEPEZZA (Biological) $103.64
- PROLENSA (Drug) $90.59
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $88.94
- LOTEMAX GEL (Drug) $66.51
- BROMSITE (Drug) $63.56
- Simbrinza (Drug) $57.48
- ALPHAGAN P (Drug) $51.82
- Catalys Laser System (Device) $46.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Daly City
Dr. Susan Longar, M.d, M.D
Ophthalmology — Payments: $2,940
Dr. Anthony Villanueva, M.d, M.D
Ophthalmology — Payments: $2,518
Alex Onishi
Ophthalmology — Payments: $2,037
Alice Shen
Ophthalmology — Payments: $2,026
Dr. Michael Hee, Md Phd, MD PHD
Ophthalmology — Payments: $1,711
Daniel Buckley, M.d, M.D
Ophthalmology — Payments: $1,308